Floatz logo

Recombinant Vesicular Stomatitis Virus-Expressing Human Interferon Beta And Sodium-Iodide Symporter

Stage III Renal Cell Cancer AJCC v8

Mayo ClinicvaccinePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

5 Active assets in the Stage III Renal Cell Cancer AJCC v8 cohort.

Asset / SponsorPhaseRating
Recombinant Human Hyaluronidase
SWOG Cancer Research Network
Phase 3B
LENVATINIB
Emory University
Phase 2CCC
Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta
Mayo Clinic
Phase 2CCC
Myrciaria Dubia Prebiotic Supplement
City of Hope Medical Center
Phase 1CC
18f-trx
Rahul Aggarwal
Phase 1CC

Same molecule, other indications

Recombinant Vesicular Stomatitis Virus-Expressing Human Interferon Beta And Sodium-Iodide Symporter is also rated in:

Advanced Clear Cell Renal Cell CarcinomaDormant
CCC
Indicative ·
53 / 100
View asset →
Recurrent Adult Acute Myeloid LeukemiaDormant
CC
Indicative ·
43 / 100
View asset →
Histiocytic and Dendritic Cell NeoplasmDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →